2024 annual financial data
Silence Therapeutics 2024 Operating margin
Silence Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -146.38%.
Operating income was -63,319,000 USD and net income was -45,309,000 USD.
Operating cash flow was -54,050,447 USD.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,258,000 USD
- Operating income
- -63,319,000 USD
- Net income
- -45,309,000 USD
- Operating cash flow
- -54,050,447 USD